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Introduction
Familial Mediterranean fever (FMF) is an autosomal
recessive disease characterized by recurring self-limited
fever, abdominal pain and chest pain caused by serositis.
FMF mainly affects Middle-East populations with a high
prevalence in Sephardic Jews, Turkish, Arabs and Arme-
nians. Carnitine is an important molecule in cellular
energy metabolism. Secondary carnitine deficiency can
be detected in chronic diseases by either renal loss or
increased needs.
Objectives
Our hypothesis was that FMF patients would have lower
free carnitine levels than their healthy age and gender
matched controls due to increased need of carnitine
because of recurrent auto-inflammation. The present
study was conducted to determine the patterns of free
carnitine and acyl-carnitine esters in FMF patients.
Methods
This is a cross-sectional study of 205 FMF patients who
were attending the outpatient Pediatric Rheumatology
clinic of Cerrahpasa Medical Faculty Children’s Hospital.
The patients were selected by random sampling and FMF
diagnosis was confirmed by a pediatric rheumatologist
according to Yalcınkaya criteria. 50 healthy subsects were
enrolled to the present study. A fasting died blood sample
was taken for studying free carnitine and acyl-carnitine
esters with tandem mass spectrometry from children in
both groups.
Results
Acyl-carnitine analyses in spot dried blood samples with
ESI-MS/MS were performed in all patients and control
group. Screening of acyl-carnitine profile revealed free
carnitine, C16-OH and C18:2 carnitine levels were higher
(p<0,0001, p<0,0001 and p-0,003 respectively), while C4-
OH and C4DC carnitine levels were lower (p<0,0001) in
FMF patients than the control group.
Conclusions
In the present study we were not able to define secondary
carnitine deficiency in FMF patients, therefore usage of
carnitine in all patients with FMF is not recommended.
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